Article Text

PDF

A clinical prediction model did well in diagnosing paediatric group A β-haemolytic streptococcal pharyngitis
  1. Chris B Del Mar, MB, BChir
  1. University of Queensland, Herston, Queensland, Australia

    Statistics from Altmetric.com

    
 
 QUESTION: In children with suspected group A β-haemolytic streptococcal (GABHS) pharyngitis, how well does a prediction model predict a positive throat culture?

    Design

    1 year validation of a previously derived prediction model.

    Setting

    Paediatric emergency department and 2 paediatric outpatient clinics in Wilmington, Delaware, USA.

    Patients

    587 children (mean age 6.8 y, 51% girls) who had signs and symptoms of acute pharyngitis. Exclusion criteria were antibiotic treatment within 5 days of enrollment.

    Description of prediction guide

    During the clinical evaluation, the examining physician recorded 4 variables from the tested model: cervical lymphadenopathy, tonsillar swelling (2 category severity scale: absent or mild and moderate or severe), coryza, and scarletiniform rash (present or absent). 2 tonsillopharyngeal specimens were collected for each patient for serotyping (diagnostic standard) and a rapid streptococcal antigen detection test. Furthermore, the physician made a subjective probability estimate for a GABHS-positive throat culture result (11-point scale: 0 = most unlikely and 10 = extremely likely).

    Main outcome measures

    A performance score was calculated for the prediction model ranging from 0 to 5, with higher scores indicating more severe indications of the clinical variables. Sensitivity, specificity, likelihood ratios, and post-test probability were calculated for cutoff points of the performance score.

    Main results

    218 children (37%) had positive culture results for GABHS. The prediction model did better than the physicians' probability estimates and was comparable to the rapid antigen detection test (table). The model did not differ in performance according to setting (emergency department v outpatient clinic) or study period (in season [January to March] v off season [April to December]).

    Validation at 1 year of a prediction model for diagnosing paediatric group A β-haemolytic streptococcal pharyngitis*

    Conclusion

    In children with suspected group A β-haemolytic streptococcal pharyngitis, a clinical prediction model predicted a positive throat culture as well as a rapid antigen detection test and better than subjective estimation by physicians.

    Commentary

    The study by Attia et al shows that clinicians are not good at estimating the presence of GABHS pharyngitis in symptomatic children (only about 50% of those subjectively estimated as being “strep positive” had a positive GABHS throat culture result). The simple predictive model described here is much more accurate (post-test probability of 79%) and almost as good as a rapid antigen test (post-test probability of 85%). Such results should encourage us to use the model for deciding on management: it is easy to use, quick, and cheaper than the rapid antigen test. However, one interesting finding from this well-conducted study was the high culture rate in the control group (children with no sore throat being seen for other reasons; 15%) compared with that in children with symptoms (37%). In children with a strep-positive culture result, distinguishing carrier state from infection remains difficult. This is a weakness of the study, unlike the study by Dagnelie et al1 in which a better measure of infection — a 4-item model (cough, exudate on the throat, fever, and neck lymph nodes) — was also compared with anti-streptolysin-O titers.

    But let us step back a moment. Why is accurate diagnosis of streptococcal sore throat and its differentiation from other causes of sore throat important? It enables us to treat “strep throat” with antibiotics to prevent acute rheumatic fever (ARF), acute glomerulonephritis, and suppurative complications, and to shorten the illness or decrease its severity. But in many areas, ARF is so rare that treating it might create as much risk from the antibiotics as there is from the disease, and the symptomatic benefits of antibiotics are so modest2 that alternative, non-antibiotic treatment3 may be as good if not better.

    Perhaps we should think carefully about what we intend to do once we diagnose GABHS before worrying too much about how to diagnose it. Only in clinical settings where ARF is common (eg, developing countries)4 or in patients with special concerns for symptomatic relief, should we concern ourselves with deciding the cause. After all, sore throats get better spontaneously.

    References

    View Abstract

    Footnotes

    • Source of funding: Nemours Research Programs.

    • For correspondence: Dr M W Attia, Department of Pediatrics, Alfred I. duPont Hospital for Children, 1600 Rockland Road, Wilmington, DE 19803, USA.mattia{at}nemours.org

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.